References
- Celeste AJ, Iannazzi JA, Taylor RC, Hewick RM, Rosen V, Wang EA, et al. 1990. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc. Natl. Acad. Sci. USA 87: 9843-9847. https://doi.org/10.1073/pnas.87.24.9843
- Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, et al. 1988. Novel regulators of bone formation: molecular clones and activities. Science 242: 1528-1534. https://doi.org/10.1126/science.3201241
- Miyazaki Y, Oshima K, Fogo A, Hogan BL, Ichikawa I. 2000. Bone morphogenetic protein 4 regulates the budding site and elongation of the mouse ureter. J. Clin. Invest. 105: 863-873. https://doi.org/10.1172/JCI8256
- Winnier G, Blessing M, Labosky PA, Hogan BL. 1995. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev. 9: 2105-2116. https://doi.org/10.1101/gad.9.17.2105
- Bragdon B, Moseychuk O, Saldanha S, King D, Julian J, Nohe A. 2011. Bone morphogenetic proteins: a critical review. Cell Signal. 23: 609-620. https://doi.org/10.1016/j.cellsig.2010.10.003
- Kim M, Choe S. 2011. BMPs and their clinical potentials. BMP Rep. 44: 619-634.
- Liu B, Tian D, Yi W, Wu L, Cai Q, Dong H, et al. 2010. Effect of bone morphogenetic protein 4 in the human brain glioma cell line U251. Cell Biochem. Biophys. 58: 91-96. https://doi.org/10.1007/s12013-010-9095-y
- Piccirillo SG, Reynolds BA, Zanetti N, Lamorte G, Binda E, Broggi G, et al. 2006. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 444: 761-765. https://doi.org/10.1038/nature05349
- Zhou Z, Sun L, Wang Y, Wu Z, Geng J, Miu W, et al. 2011. Bone morphogenetic protein 4 inhibits cell proliferation and induces apoptosis in glioma stem cells. Cancer Biother. Radiopharm. 26: 77-83. https://doi.org/10.1089/cbr.2010.0857
- Duggal R, Geissinger U, Zhang Q, Aguilar J, Chen NG, Binda E, et al. 2013. Vaccinia virus expressing bone morphogenetic protein-4 in novel glioblastoma orthotopic models facilitates enhanced tumor regression and long-term survival. J. Transl. Med. 11: 155. https://doi.org/10.1186/1479-5876-11-155
- Lombardo Y, Scopelliti A, Cammareri P, Todaro M, Iovino F, Ricci-Vitiani L, et al. 2011. Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice. Gastroenterology 140: 297-309. https://doi.org/10.1053/j.gastro.2010.10.005
- Cui Y, Jean F, Thomas G, Christian JL. 1998. BMP-4 is proteolytically activated by furin and/or PC6 during vertebrate embryonic development. EMBO J. 17: 4735-4743. https://doi.org/10.1093/emboj/17.16.4735
- Nelsen SM, Christian JL. 2009. Site-specific cleavage of BMP4 by furin, PC6, and PC7. J. Biol. Chem. 284: 27157-27166. https://doi.org/10.1074/jbc.M109.028506
- Kim CL, Bang YL, Kim YS, Jang JW, Lee GM. 2016. Alleviation of proteolytic degradation of recombinant human bone morphogenetic protein-4 by repeated batch culture of Chinese hamster ovary cells. Process Biochem. 51: 1078-1084. https://doi.org/10.1016/j.procbio.2016.05.007
- Bessa PC, Cerqueira MT, Rada T, Gomes ME, Neves NM, Nobre A, et al. 2009. Expression, purification and osteogenic bioactivity of recombinant human BMP-4, -9, -10, -11 and -14. Protein Expr. Purif. 63: 89-94. https://doi.org/10.1016/j.pep.2008.09.014
- Klosch B, Furst W, Kneidinger R, Schuller M, Rupp B, Banerjee A, et al. 2005. Expression and purification of biologically active rat bone morphogenetic protein-4 produced as inclusion bodies in recombinant Escherichia coli. Biotechnol. Lett. 27: 1559-1564. https://doi.org/10.1007/s10529-005-1794-x
- Huang Y, Zhen B, Lin Y, Cai Y, Lin Z, Deng C, et al. 2014. Expression of codon optimized human bone morphogenetic protein 4 in Pichia pastoris. Biotechnol. Appl. Biochem. 61: 175-183. https://doi.org/10.1002/bab.1146
- Kozak M. 1984. Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs. Nucleic Acids Res. 12: 857-872. https://doi.org/10.1093/nar/12.2.857
- Yoon J, Baek K, Byun T, Park J. 2014. Expression vector animal cells. US Patent Publication No. 20140038233.
- Choi B, Lee Y, Pi J, Jeong Y, Baek K, Yoon J. 2015. Overproduction of recombinant human transforming growth factor beta 3 in Chinese hamster ovary cells. Protein Expr. Purif. 110: 102-106. https://doi.org/10.1016/j.pep.2015.02.014
- Ciudad CJ, Urlaub G, Chasin LA. 1988. Deletion analysis of the Chinese hamster dihydrofolate reductase gene promoter. J. Biol. Chem. 263: 16274-16282.
- Foster B, Germain B, Hammerstone K. 2003. Novel TGF-beta protein purification methods. US Patent Publication No. 20030036629 A1.
- Zhang F, Ren L, Lin H, Yin M, Tong Y, Shi G. 2012. The optimal dose of recombinant human osteogenic protein-1 enhances differentiation of mouse osteoblast-like cells: an in vitro study. Arch. Oral Biol. 57: 460-468. https://doi.org/10.1016/j.archoralbio.2011.10.008
- Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins MR, Appel RD, et al. 2005. Protein identification and analysis tools on the ExPASy server, pp. 571-607. In Walker J (ed.). The Proteomics Protocols Handbook. Humana, Press, New York.
- Isaacs NW. 1995. Cystine knots. Curr. Opin. Struct. Biol. 5: 391-395. https://doi.org/10.1016/0959-440X(95)80102-2
Cited by
- Efficient production process of bioactive recombinant human leukemia inhibitory factor in Chinese hamster ovary cells vol.176, pp.None, 2017, https://doi.org/10.1016/j.pep.2020.105744